Cannell & Co’s St Jude Medical STJ Stock Holding History

Cannell & Co’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-73,175	Closed	-$4.03M	–	270
2016 Q1	$4.03M	Hold	73,175	–	–	0.14%	110
2015 Q4	$4.52M	Sell	73,175 -250	-0.3%	-$15.8K	0.15%	104
2015 Q3	$4.63M	Sell	73,425 -225	-0.3%	-$16.1K	0.15%	104
2015 Q2	$5.38M	Hold	73,650	–	–	0.15%	106
2015 Q1	$4.82M	Buy	73,650 +20,000	+37%	+$1.33M	0.14%	107
2014 Q4	$3.49M	Sell	53,650 -100	-0.2%	-$6.44K	0.1%	121
2014 Q3	$3.23M	Hold	53,750	–	–	0.1%	131
2014 Q2	$3.72M	Buy	53,750 +5,350	+11%	+$347K	0.11%	123
2014 Q1	$3.17M	Sell	48,400 -33,180	-41%	-$2.16M	0.1%	127
2013 Q4	$5.05M	Buy	81,580 +150	+0.2%	+$8.69K	0.24%	59
2013 Q3	$4.37M	Sell	81,430 -200	-0.2%	-$10.3K	0.24%	59
2013 Q2	$3.73M	Buy	+81,630	New	+$3.54M	0.22%	64

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cannell & Co's STJ Position: Q2 2016 in Review

Cannell & Co sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 73,175 shares — an estimated $4.03M sold.

Cannell & Co first reported a position in STJ in Q2 2013 and held it in 12 quarters. The position peaked at $5.38M in Q2 2015. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

Cannell & Co reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
Cannell & Co sold 73,175 St Jude Medical shares in Q2 2016, an estimated $4.03M.
Cannell & Co first reported a position in St Jude Medical in Q2 2013 and held it in 12 quarters.
Cannell & Co's St Jude Medical position peaked at $5.38M in Q2 2015.
615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Cannell & Co's 13F filing for Q2 2016, filed 11 Aug 2016.